Occam Places Jeb Ledell as COO at Aveo Oncology

AVEO Oncology (Nasdaq: AVEO) is a commercial stage, oncology-focused biopharmaceutical company. Aveo was acquired by LG Chem for $600M in October of 2022.

In late 2021, Occam placed Jeb Ledell as COO of AVEO. Jeb joined AVEO from Enzyvant Therapeutics, a biotech company dedicated to developing novel, transformative regenerative therapies with rare diseases, where he served as COO. Prior to Enzyvant, Jeb served as COO at Compass Therapeutics and Horizon Discovery Group.

Jeb Ledell
12.6.21
COO

View recent Placements

Placement Card Link
Cole Zimmerman
8.10.26
Occam Global Recruits Commercial Leader to Bexorg
Placement Card Link
David Dickerhoff
8.3.26
Occam Recruits Head of Manufacturing for Edge Animal Health
Placement Card Link
Julie O'Shaughnessy
7.21.26
Occam Places Julie O'Shaughnessy as President of Conceivable Life Sciences
Placement Card Link
Kim Branson, PhD
6.23.26
Occam Recruits AIDD Pioneer Kim Branson to Cradle Advisory Board

DISCOVER OCCAM GLOBAL

Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide.  Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.

Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression.  Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.

LEARN HOW OCCAM GLOBAL CAN PARTNER WITH YOU IN HIGH-STAKES LEADERSHIP DECISIONS.

COO